arXiv preprint ·

Enhancing Type 2 Diabetes Diagnosis with Evolutionary Algorithms and Machine Learning

Parisa Rezaei, Mohsen Saffar, Hamid Reza Naji, Mohammad Mehdi Faghih and Rasoul Nouriazar

Published
Source
arXiv preprint, posted before peer review
DOI
10.1109/ICBME68496.2025.11392543
Original
Read it at arXiv
Topics
Machine Learning

In brief

A Smarter Search for Diabetes Signals

The authors pair Bat Optimization with Random Forest to select features and tune model settings, after cleaning and rebalancing the data with SMOTE-ENN. They report 89% accuracy and better overall performance than the baseline Random Forest and other approaches they compared against.

What they found: On the Pima Indians Diabetes Database, the optimized model achieved 89% accuracy, 88% precision, 90% recall, and an 89% F1-score. The authors report that it outperformed the baseline Random Forest and other existing approaches. The findings support the promise of combining evolutionary optimization with ensemble learning on this dataset.

AI-written summary. Check anything you rely on against the original paper.

Abstract

Type 2 diabetes is a widespread chronic disease that requires early and accurate diagnosis to prevent serious complications. Traditional diagnostic methods often lack sufficient accuracy, which highlights the need for more reliable computational solutions. In this study, we propose a model that integrates the Random Forest classifier with the Bat Optimization Algorithm for simultaneous feature selection and hyperparameter tuning. The SMOTE-ENN method was first applied to the Pima Indians Diabetes Database to correct class imbalance and remove noisy or ambiguous samples, producing a more balanced and cleaner dataset. The optimized model trained on this refined dataset achieved 89% accuracy, 88% precision, 90% recall, and an F1-score of 89%, clearly outperforming the baseline Random Forest and other existing approaches. These results demonstrate the potential of combining evolutionary algorithms with ensemble learning to provide a practical and cost-effective tool for early detection of type 2 diabetes in clinical practice.

The authors’ abstract, as arXiv lists it. arXiv’s listings, abstracts included, are free for anyone to reuse.

Read it on ReadSearch

Each opens after you create an account, and brings you back to this paper.

Already a reader? Sign in

All new papers in Machine Learning

Get the few papers worth your time in Machine Learning every morning.

ReadSearch reads the new papers in your field each day and brings you the few worth reading, each with its key finding in a sentence.

Papers belong to their authors and publishers; every page here links to the original. All research topics